Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹264.60
12.97 (4.67%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹8.59K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
5.8
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹108+145.0%
52W High₹289-8.4%
Current Price
₹264.60
Circuit Limits (10%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹238.14
Upper Circuit₹291.06
Reference Price
₹264.60
Investment Checklist
Ascending Channel on 1D — target ₹272.54
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 54.95 (BUY) with 54.7% confidence
News: Renault India joins hands with IIT Kanpur for vehicle R&D...
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
55%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
243.19
EMA50
214.27
EMA200
167.71
Price Action
UPTREND
BULLISH
Higher Highs6
Higher Lows7
Lower Highs3
Lower Lows2
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹253.17
₹248.75
₹220.05
₹194.10
₹182.59
Volume Analysis
TrendSTABLE
Change+0.90%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹261.95
3% Risk₹256.66
5% Risk₹251.37
7% Risk (Custom)
₹246.08Technical Levels
1x ATR (Volatility)₹250.17
2x ATR (Swing)₹235.74
3x ATR (Trend)₹221.31
Immediate Support₹253.17
Moving Averages
EMA 9 (Short-term)₹257.53
EMA 20 (Medium-term)₹243.19
EMA 50 (Trend)₹214.27
EMA 200 (Long-term)₹167.71
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹27.2 Cr | ₹9.6 Cr | ₹7.9 Cr | ₹8.5 Cr |
| Net Profit | ₹-59.8 Cr | ₹-51.9 Cr | ₹-75.9 Cr | ₹-80.4 Cr |
| EPS | — | ₹-1.60 | ₹-2.34 | ₹-2.48 |
| Operating Profit | ₹-53.7 Cr | ₹-42.9 Cr | ₹-65.7 Cr | ₹-69 Cr |
ROE
157.88%
ROCE
-693.64%
Debt/Equity
-1.22
Current Ratio
0.07
OPM
-816.57%
NPM
-951.72%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Sun Pharma Advanced Research Company Limited | ₹264.60 | -4.67% | 5.8 | ₹8.59K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 21 Sept 2021 | Annual General Meeting | AGM |
| 22 Sept 2020 | Annual General Meeting | AGM |
| 18 Jul 2019 | Annual General Meeting | AGM |
| 19 Jul 2018 | Annual General Meeting | AGM |
| 27 Jul 2017 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SPARC
View All
positive
NDTV Profit 16h ago
Sun Pharma Q1 Results: Date, Time, Dividend News, Earnings Call Schedule And More
Sun Pharma Q1 Result Details.
DIVIDENDSPARCFinancial ServicesHealthcare
positive
ET Markets - Industry 23h ago
Renault India joins hands with IIT Kanpur for vehicle R&D
Renault India and IIT Kanpur have formed a strategic research partnership. The collaboration will utilize IIT Kanpur's wind tunnel facility for vehicle testing. This initiative aims to enhance Renault's engineering capabilities within India. Advanced aerodynamic and wind-noise testing will be conducted on passenger vehicles. The agreement establishes a framework for commercial engagement and intellectual property.
HGINFRAMBELSPARCTMPVZFCVINDIAAutomobile and Auto ComponentsConstruction
NEWS
positive
Business Standard - Markets 1d ago
Indices trade higher; European mrkt advance
PSU Bank, Realty and IT shares advanced while pharma and FMCG shares declined.
ADVANCEBANKINDIABANKPSUGROWWPSUBKHDFCPSUBKPSUBANKPSUBANKADDPSUBNKBEESPSUBNKIETFSBIBPBSPARCChemicalsFinancial Services